CIK 0000883107 · Non-accelerated filer<br>Smaller reporting company
SOLESENCE, INC.
Sign in to watch- Ticker
- SLSN
- Exchange
- Nasdaq
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363687863
- Phone
- 6307716078
- Business address
- 1319 MARQUETTE DRIVE, ROMEOVILLE, IL, 60446
- Former names
- NANOPHASE TECHNOLOGIES Corp, NANOPHASE TECHNOLOGIES CORPORATION
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-08 | WHITMORE BRADFORD T 10% owner | Purchase | +952,697 | $0.40 | $381K | 8,684,270 |
| 2024-02-08 | WHITMORE BRADFORD T 10% owner | Purchase | +74,105 | $0.40 | $30K | 675,515 |
| 2024-02-08 | WHITMORE BRADFORD T 10% owner | Purchase | +6,337 | $0.40 | $3K | 57,791 |
| 2024-01-23 | Cureton Kevin Chief Operating Officer | Option exercise | +25,000 | $0.52 | $13K | 125,821 |
| 2024-01-23 | Cureton Kevin Chief Operating Officer | Returned to the company · Common Stock (right to purchase) | −25,000 | $0.52 | $13K | 0 |
| 2024-01-19 | JANKOWSKI JESS President, CEO | Option exercise | +67,450 | $0.52 | $35K | 126,450 |
| 2024-01-19 | JANKOWSKI JESS President, CEO | Returned to the company · Common Stock (right to purchase) | −67,450 | $0.52 | $35K | 0 |
| 2023-12-27 | Miller Mark E Director | Grant or award · Common Stock (option to purchase) | +12,600 | $0.61 | $8K | 12,600 |
| 2023-12-27 | JANKOWSKI JESS President, CEO | Grant or award · Common Stock (right to purchase) | +12,600 | $0.61 | $8K | 12,600 |
| 2023-12-27 | Beres Laura M Director | Grant or award · Common Stock (option to purchase) | +12,600 | $0.61 | $8K | 12,600 |
| 2023-12-27 | Cureton Kevin Chief Operating Officer | Grant or award · Common Stock (right to purchase) | +12,600 | $0.61 | $8K | 12,600 |
| 2023-12-27 | WHITMORE R JANET Director | Grant or award · Common Stock (right to purchase) | +12,600 | $0.61 | $8K | 12,600 |
| 2023-09-08 | JANKOWSKI JESS President, CEO | Option exercise | +2,500 | $0.52 | $1K | 61,500 |
| 2023-09-08 | JANKOWSKI JESS President, CEO | Sale | −2,500 | $1.00 | $3K | 59,000 |
| 2023-09-08 | JANKOWSKI JESS President, CEO | Option exercise · Common Stock (right to purchase) | −2,500 | $0.52 | $1K | 67,450 |
| 2023-09-07 | JANKOWSKI JESS President, CEO | Option exercise | +2,500 | $0.52 | $1K | 61,500 |
| 2023-09-07 | JANKOWSKI JESS President, CEO | Sale | −2,500 | $1.00 | $3K | 59,000 |
| 2023-09-07 | JANKOWSKI JESS President, CEO | Option exercise · Common Stock (right to purchase) | −2,500 | $0.52 | $1K | 69,950 |
| 2023-09-06 | JANKOWSKI JESS President, CEO | Option exercise | +1,000 | $0.52 | $520 | 60,000 |
| 2023-09-06 | JANKOWSKI JESS President, CEO | Sale | −1,000 | $1.00 | $1K | 59,000 |
Page 6 of 19 · 367 trades